
From the U.S. Code Online via GPO Access
[wais.access.gpo.gov]
[Laws in effect as of January 2, 2001]
[Document not affected by Public Laws enacted between
  January 2, 2001 and January 28, 2002]
[CITE: 21USC1705]

 
                        TITLE 21--FOOD AND DRUGS
 
                CHAPTER 22--NATIONAL DRUG CONTROL POLICY
 
Sec. 1705. Development, submission, implementation, and 
        assessment of National Drug Control Strategy
        

(a) Timing, contents, and process for development and submission of 
        National Drug Control Strategy

                             (1) Timing

        Not later than February 1, 1999, the President shall submit to 
    Congress a National Drug Control Strategy, which shall set forth a 
    comprehensive plan, covering a period of not more than 5 years, for 
    reducing drug abuse and the consequences of drug abuse in the United 
    States, by limiting the availability of and reducing the demand for 
    illegal drugs.

                            (2) Contents

        (A) In general

            The National Drug Control Strategy submitted under paragraph 
        (1) shall include--
                (i) comprehensive, research-based, long-range, 
            quantifiable, goals for reducing drug abuse and the 
            consequences of drug abuse in the United States;
                (ii) annual, quantifiable, and measurable objectives and 
            specific targets to accomplish long-term quantifiable goals 
            that the Director determines may be achieved during each 
            year of the period beginning on the date on which the 
            National Drug Control Strategy is submitted;
                (iii) 5-year projections for program and budget 
            priorities; and
                (iv) a review of international, State, local, and 
            private sector drug control activities to ensure that the 
            United States pursues well-coordinated and effective drug 
            control at all levels of government.

        (B) Classified information

            Any contents of the National Drug Control Strategy that 
        involves information properly classified under criteria 
        established by an Executive order shall be presented to Congress 
        separately from the rest of the National Drug Control Strategy.

             (3) Process for development and submission

        (A) Consultation

            In developing and effectively implementing the National Drug 
        Control Strategy, the Director--
                (i) shall consult with--
                    (I) the heads of the National Drug Control Program 
                agencies;
                    (II) Congress;
                    (III) State and local officials;
                    (IV) private citizens and organizations with 
                experience and expertise in demand reduction;
                    (V) private citizens and organizations with 
                experience and expertise in supply reduction; and
                    (VI) appropriate representatives of foreign 
                governments;

                (ii) with the concurrence of the Attorney General, may 
            require the El Paso Intelligence Center to undertake 
            specific tasks or projects to implement the National Drug 
            Control Strategy; and
                (iii) with the concurrence of the Director of Central 
            Intelligence and the Attorney General, may request that the 
            National Drug Intelligence Center undertake specific tasks 
            or projects to implement the National Drug Control Strategy.

        (B) Inclusion in Strategy

            The National Drug Control Strategy under this subsection, 
        and each report submitted under subsection (b) of this section, 
        shall include a list of each entity consulted under subparagraph 
        (A)(i).

                        (4) Specific targets

        The targets in the National Drug Control Strategy shall include 
    the following:
            (A) Reduction of unlawful drug use to 3 percent of the 
        population of the United States or less by December 31, 2003 (as 
        measured in terms of overall illicit drug use during the past 30 
        days by the National Household Survey), and achievement of at 
        least 20 percent of such reduction during each of 1999, 2000, 
        2001, 2002, and 2003.
            (B) Reduction of adolescent unlawful drug use (as measured 
        in terms of illicit drug use during the past 30 days by the 
        Monitoring the Future Survey of the University of Michigan or 
        the National PRIDE Survey conducted by the National Parents' 
        Resource Institute for Drug Education) to 3 percent of the 
        adolescent population of the United States or less by December 
        31, 2003, and achievement of at least 20 percent of such 
        reduction during each of 1999, 2000, 2001, 2002, and 2003.
            (C) Reduction of the availability of cocaine, heroin, 
        marijuana, and methamphetamine in the United States by 80 
        percent by December 31, 2003.
            (D) Reduction of the respective nationwide average street 
        purity levels for cocaine, heroin, marijuana, and 
        methamphetamine (as estimated by the interagency drug flows 
        assessment led by the Office of National Drug Control Policy, 
        and based on statistics collected by the Drug Enforcement 
        Administration and other National Drug Control Program agencies 
        identified as relevant by the Director) by 60 percent by 
        December 31, 2003, and achievement of at least 20 percent of 
        each such reduction during each of 1999, 2000, 2001, 2002, and 
        2003.
            (E) Reduction of drug-related crime in the United States by 
        50 percent by December 31, 2003, and achievement of at least 20 
        percent of such reduction during each of 1999, 2000, 2001, 2002, 
        and 2003, including--
                (i) reduction of State and Federal unlawful drug 
            trafficking and distribution;
                (ii) reduction of State and Federal crimes committed by 
            persons under the influence of unlawful drugs;
                (iii) reduction of State and Federal crimes committed 
            for the purpose of obtaining unlawful drugs or obtaining 
            property that is intended to be used for the purchase of 
            unlawful drugs; and
                (iv) reduction of drug-related emergency room incidents 
            in the United States (as measured by data of the Drug Abuse 
            Warning Network on illicit drug abuse), including incidents 
            involving gunshot wounds and automobile accidents in which 
            illicit drugs are identified in the bloodstream of the 
            victim, by 50 percent by December 31, 2003.

     (5) Further reductions in drug use, availability, and crime

        Following the submission of a National Drug Control Strategy 
    under this section to achieve the specific targets described in 
    paragraph (4), the Director may formulate a strategy for additional 
    reductions in drug use and availability and drug-related crime 
    beyond the 5-year period covered by the National Drug Control 
    Strategy that has been submitted.

(b) Annual Strategy report

                           (1) In general

        Not later than February 1, 1999, and on February 1 of each year 
    thereafter, the President shall submit to Congress a report on the 
    progress in implementing the Strategy under subsection (a) of this 
    section, which shall include--
            (A) an assessment of the Federal effectiveness in achieving 
        the National Drug Control Strategy goals and objectives using 
        the performance measurement system described in subsection (c) 
        of this section, including--
                (i) an assessment of drug use and availability in the 
            United States; and
                (ii) an estimate of the effectiveness of interdiction, 
            treatment, prevention, law enforcement, and international 
            programs under the National Drug Control Strategy in effect 
            during the preceding year, or in effect as of the date on 
            which the report is submitted;

            (B) any modifications of the National Drug Control Strategy 
        or the performance measurement system described in subsection 
        (c) of this section;
            (C) an assessment of the manner in which the budget proposal 
        submitted under section 1703(c) of this title is intended to 
        implement the National Drug Control Strategy and whether the 
        funding levels contained in such proposal are sufficient to 
        implement such Strategy;
            (D) measurable data evaluating the success or failure in 
        achieving the annual measurable objectives described in 
        subsection (a)(2)(A)(ii) of this section;
            (E) an assessment of current drug use (including inhalants) 
        and availability, impact of drug use, and treatment 
        availability, which assessment shall include--
                (i) estimates of drug prevalence and frequency of use as 
            measured by national, State, and local surveys of illicit 
            drug use and by other special studies of--
                    (I) casual and chronic drug use;
                    (II) high-risk populations, including school 
                dropouts, the homeless and transient, arrestees, 
                parolees, probationers, and juvenile delinquents; and
                    (III) drug use in the workplace and the productivity 
                lost by such use;

                (ii) an assessment of the reduction of drug availability 
            against an ascertained baseline, as measured by--
                    (I) the quantities of cocaine, heroin, marijuana, 
                methamphetamine, and other drugs available for 
                consumption in the United States;
                    (II) the amount of marijuana, cocaine, heroin, and 
                precursor chemicals entering the United States;
                    (III) the number of hectares of marijuana, poppy, 
                and coca cultivated and destroyed domestically and in 
                other countries;
                    (IV) the number of metric tons of marijuana, heroin, 
                cocaine, and methamphetamine seized;
                    (V) the number of cocaine and methamphetamine 
                processing laboratories destroyed domestically and in 
                other countries;
                    (VI) changes in the price and purity of heroin and 
                cocaine, changes in the price of methamphetamine, and 
                changes in tetrahydrocannabinol level of marijuana;
                    (VII) the amount and type of controlled substances 
                diverted from legitimate retail and wholesale sources; 
                and
                    (VIII) the effectiveness of Federal technology 
                programs at improving drug detection capabilities in 
                interdiction, and at United States ports of entry;

                (iii) an assessment of the reduction of the consequences 
            of drug use and availability, which shall include estimation 
            of--
                    (I) the burden drug users placed on hospital 
                emergency departments in the United States, such as the 
                quantity of drug-related services provided;
                    (II) the annual national health care costs of drug 
                use, including costs associated with people becoming 
                infected with the human immunodeficiency virus and other 
                infectious diseases as a result of drug use;
                    (III) the extent of drug-related crime and criminal 
                activity; and
                    (IV) the contribution of drugs to the underground 
                economy, as measured by the retail value of drugs sold 
                in the United States;

                (iv) a determination of the status of drug treatment in 
            the United States, by assessing--
                    (I) public and private treatment capacity within 
                each State, including information on the treatment 
                capacity available in relation to the capacity actually 
                used;
                    (II) the extent, within each State, to which 
                treatment is available;
                    (III) the number of drug users the Director 
                estimates could benefit from treatment; and
                    (IV) the specific factors that restrict the 
                availability of treatment services to those seeking it 
                and proposed administrative or legislative remedies to 
                make treatment available to those individuals; and

                (v) a review of the research agenda of the Counter-Drug 
            Technology Assessment Center to reduce the availability and 
            abuse of drugs; and

            (F) an assessment of private sector initiatives and 
        cooperative efforts between the Federal Government and State and 
        local governments for drug control.

                 (2) Submission of revised Strategy

        The President may submit to Congress a revised National Drug 
    Control Strategy that meets the requirements of this section--
            (A) at any time, upon a determination by the President, in 
        consultation with the Director, that the National Drug Control 
        Strategy in effect is not sufficiently effective; and
            (B) if a new President or Director takes office.

                      (3) 1999 Strategy report

        With respect to the Strategy report required to be submitted by 
    this subsection on February 1, 1999, the President shall prepare the 
    report using such information as is available for the period covered 
    by the report.

(c) Performance measurement system

                        (1) Sense of Congress

        It is the sense of Congress that--
            (A) the targets described in subsection (a) of this section 
        are important to the reduction of overall drug use in the United 
        States;
            (B) the President should seek to achieve those targets 
        during the 5 years covered by the National Drug Control Strategy 
        required to be submitted under subsection (a) of this section;
            (C) the purpose of such targets and the annual reports to 
        Congress on the progress towards achieving the targets is to 
        allow for the annual restructuring of appropriations by the 
        Appropriations Committees and authorizing committees of 
        jurisdiction of Congress to meet the goals described in this 
        chapter;
            (D) the performance measurement system developed by the 
        Director described in this subsection is central to the National 
        Drug Control Program targets, programs, and budget;
            (E) the Congress strongly endorses the performance 
        measurement system for establishing clear outcomes for reducing 
        drug use nationwide during the next five years, and the linkage 
        of this system to all agency drug control programs and budgets 
        receiving funds scored as drug control agency funding.

                     (2) Submission to Congress

        Not later than February 1, 1999, the Director shall submit to 
    Congress a description of the national drug control performance 
    measurement system, designed in consultation with affected National 
    Drug Control Program agencies, that--
            (A) develops performance objectives, measures, and targets 
        for each National Drug Control Strategy goal and objective;
            (B) revises performance objectives, measures, and targets, 
        to conform with National Drug Control Program Agency budgets;
            (C) identifies major programs and activities of the National 
        Drug Control Program agencies that support the goals and 
        objectives of the National Drug Control Strategy;
            (D) evaluates in detail the implementation by each National 
        Drug Control Program agency of program activities supporting the 
        National Drug Control Strategy;
            (E) monitors consistency between the drug-related goals and 
        objectives of the National Drug Control Program agencies and 
        ensures that drug control agency goals and budgets support and 
        are fully consistent with the National Drug Control Strategy; 
        and
            (F) coordinates the development and implementation of 
        national drug control data collection and reporting systems to 
        support policy formulation and performance measurement, 
        including an assessment of--
                (i) the quality of current drug use measurement 
            instruments and techniques to measure supply reduction and 
            demand reduction activities;
                (ii) the adequacy of the coverage of existing national 
            drug use measurement instruments and techniques to measure 
            the casual drug user population and groups that are at risk 
            for drug use; and
                (iii) the actions the Director shall take to correct any 
            deficiencies and limitations identified pursuant to 
            subparagraphs (A) and (B) of subsection (b)(4) of this 
            section.

                          (3) Modifications

        A description of any modifications made during the preceding 
    year to the national drug control performance measurement system 
    described in paragraph (2) shall be included in each report 
    submitted under subsection (b) of this section.

(Pub. L. 105-277, div. C, title VII, Sec. 706, Oct. 21, 1998, 112 Stat. 
2681-681.)

                            Repeal of Section

        For repeal of section on Sept. 30, 2003, see section 1712 of 
    this title.

                       References in Text

    This chapter, referred to in subsec. (c)(1)(C), was in the original 
``this Act'' and was translated as reading ``this title'', meaning title 
VII of Pub. L. 105-277, div. C, Oct. 21, 1998, 112 Stat. 2681-670, which 
is classified principally to this chapter, to reflect the probable 
intent of Congress. For complete classification of title VII to the 
Code, see Short Title note set out under section 1701 of this title and 
Tables.

                  Section Referred to in Other Sections

    This section is referred to in sections 1701, 1703, 1709 of this 
title.
